These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28881139)

  • 1. Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.
    Wang Y; Newman MR; Ackun-Farmmer M; Baranello MP; Sheu TJ; Puzas JE; Benoit DSW
    ACS Nano; 2017 Sep; 11(9):9445-9458. PubMed ID: 28881139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic Efficacy.
    Xiao B; Ackun-Farmmer MA; Adjei-Sowah E; Liu Y; Chandrasiri I; Benoit DSW
    ACS Biomater Sci Eng; 2024 Apr; 10(4):2224-2234. PubMed ID: 38537162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-Targeted Nanoparticle Drug Delivery System-Mediated Macrophage Modulation for Enhanced Fracture Healing.
    Xiao B; Liu Y; Chandrasiri I; Adjei-Sowah E; Mereness J; Yan M; Benoit DSW
    Small; 2024 Feb; 20(7):e2305336. PubMed ID: 37797180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous activation of Wnt/β-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing.
    Lauing KL; Sundaramurthy S; Nauer RK; Callaci JJ
    Alcohol Alcohol; 2014; 49(4):399-408. PubMed ID: 24627571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
    Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
    PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing.
    Wang Y; Malcolm DW; Benoit DSW
    Biomaterials; 2017 Sep; 139():127-138. PubMed ID: 28601703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary phlorizin enhances osteoblastogenic bone formation through enhancing β-catenin activity via GSK-3β inhibition in a model of senile osteoporosis.
    Antika LD; Lee EJ; Kim YH; Kang MK; Park SH; Kim DY; Oh H; Choi YJ; Kang YH
    J Nutr Biochem; 2017 Nov; 49():42-52. PubMed ID: 28866105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.
    Gu Y; Wang Z; Shi J; Wang L; Hou Z; Guo X; Tao Y; Wu X; Zhou W; Liu Y; Zhang W; Xu Y; Yang H; Xue F; Geng D
    Cell Death Dis; 2017 Jun; 8(6):e2878. PubMed ID: 28617442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing long non-coding RNA MEG3 accelerates tibia fraction healing by regulating the Wnt/β-catenin signalling pathway.
    Liu YB; Lin LP; Zou R; Zhao QH; Lin FQ
    J Cell Mol Med; 2019 Jun; 23(6):3855-3866. PubMed ID: 30955246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unleashing β-catenin with a new anti-Alzheimer drug for bone tissue regeneration.
    Comeau-Gauthier M; Tarchala M; Luna JLR; Harvey E; Merle G
    Injury; 2020 Nov; 51(11):2449-2459. PubMed ID: 32829895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of beta-catenin signaling by Pb leads to incomplete fracture healing.
    Beier EE; Sheu TJ; Buckley T; Yukata K; O'Keefe R; Zuscik MJ; Puzas JE
    J Orthop Res; 2014 Nov; 32(11):1397-405. PubMed ID: 25044211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways.
    Lin FX; Zheng GZ; Chang B; Chen RC; Zhang QH; Xie P; Xie D; Yu GY; Hu QX; Liu DZ; Du SX; Li XD
    Cell Physiol Biochem; 2018; 47(1):161-175. PubMed ID: 29763908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage depletion increases target specificity of bone-targeted nanoparticles.
    Ackun-Farmmer MA; Xiao B; Newman MR; Benoit DSW
    J Biomed Mater Res A; 2022 Jan; 110(1):229-238. PubMed ID: 34319645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling.
    Jin H; Wang B; Li J; Xie W; Mao Q; Li S; Dong F; Sun Y; Ke HZ; Babij P; Tong P; Chen D
    Bone; 2015 Feb; 71():63-75. PubMed ID: 25263522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism.
    Tatsumoto N; Arioka M; Yamada S; Takahashi-Yanaga F; Tokumoto M; Tsuruya K; Kitazono T; Sasaguri T
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27803315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
    J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
    Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
    Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.